e-ISSN 1309-2545      ISSN 1301-062X

Download Current Issue.

Volume : 27 Issue : 3 Year : 2021

Current Issue Archive Popular Articles Ahead of Print Submit Your Article Login
Turkish Journal of Neurology Indexed By
  Association between PSEN1 p.E318G Variant and APOE Polymorphism and Alzheimer Disease in Turkish Patients [Turk J Neurol]
Turk J Neurol. 2021; 27(2): 117-122 | DOI: 10.4274/tnd.2021.22316  

Association between PSEN1 p.E318G Variant and APOE Polymorphism and Alzheimer Disease in Turkish Patients

Gamze Güven1, Haşmet Hanağası2, Ebba Lohmann3, Nihan Erginel Ünaltuna1, Hakan Gürvit2, Rukiye Aslan1, Çağla Dönmez1, Başar Bilgiç2
1İstanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Genetics, Istanbul, Turkey
2İstanbul University-Istanbul Faculty of Medicine, Department of Neurology, Unit of Behavioural Neurology and Movement Disorders, Istanbul, Turkey
3Tübingen University, Hertie-Institute For Clinical Brain Research, Department of Neurodegenerative Diseases, Tübingen, Germany; DZNE, German Center For Neurodegenerative Diseases, Tübingen, Germany

Objective: Mutations in the Presenilin-1 (PSEN1) gene have been associated with early-onset familial Alzheimer disease (AD) and these mutations usually exhibit full penetrance. However, the p.E318G variant located at exon 9 of PSEN1 is an exception. This variant is also seen in non-demented controls other than patients with AD suggesting that it may be a rare polymorphism or a mutation with low penetrance. In addition, results from studies conducted in different populations investigating the role of p.E318G variant in AD were conflicting. In this study, we aimed to determine the frequency of the PSEN1 p.E318G variant and APOE genotypes in a Turkish cohort and to investigate whether they were associated with the risk of AD.
Materials and Methods: The study included 217 patients with familial AD, 153 patients with sporadic AD, and 402 controls. The PSEN1 p.E318G and APOE genotypes were determined using real-time polymerase chain reaction with hydrolysis probes.
Results: The p.E318G variant was found in five patients with familial AD, three patients with sporadic AD, and 11 control subjects. There was no significant difference in the distribution of the p.E318G variant between patients and controls in familial and sporadic forms. APOE ε4 allele carriers had an increased risk for AD compared with non-carriers both in familial [odds ratio (OR): 3.67, 95% confidence interval (CI): (2.69-4.99); p<0.001] and sporadic cases [OR: 2.91, 95% CI: (2.06-4.10); p<0.001]. No significant difference was found in the distribution of the p.E318G variant with either the absence or presence of the APOE ε4 allele.
Conclusion: Our results showed that PSEN1 p.E318G variation, either alone or together with the APOE ε4 allele, is not associated with AD risk in Turkish patients with AD. However, the APOE ε4 allele constitutes a significant risk factor for AD both in familial and sporadic forms.

Keywords: Alzheimer disease, presenilin-1, E318G variant, APOE ε, 4

Gamze Güven, Haşmet Hanağası, Ebba Lohmann, Nihan Erginel Ünaltuna, Hakan Gürvit, Rukiye Aslan, Çağla Dönmez, Başar Bilgiç. Association between PSEN1 p.E318G Variant and APOE Polymorphism and Alzheimer Disease in Turkish Patients. Turk J Neurol. 2021; 27(2): 117-122

Corresponding Author: Gamze Güven, Türkiye

English Full Text
Download citation
Reference Manager
Share with email
Send email to author

Similar articles
Google Scholar

© Copyright 2021 Turkish Journal of Neurology
Home        |        Contact
LookUs & OnlineMakale